NCT00621374
- Conditions
- Agnosia, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +11 more
- Locations
-
- University of Washington Seattle, Washington, United States
Clinical trial condition
Multiple Sclerosis
Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.
2,009 public trials
298 recruiting studies
Multiple Sclerosis trial results
NCT00086671
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Site Reference ID/Investigator# 107 Phoenix, Arizona, United States
- Site Reference ID/Investigator# 163 Sun City, Arizona, United States
- Site Reference ID/Investigator# 156 Little Rock, Arkansas, United States
- Site Reference ID/Investigator# 154 Irvine, California, United States
NCT00134563
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Sanofi-Aventis Bridgewater, New Jersey, United States
- Sanofi-Aventis Austria Vienna, Austria
- sanofi-aventis, Canada Laval, Canada
- Sanofi-Aventis Santiago, Chile
NCT00811395
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
- Sanofi-Aventis Administrative Office Vienna, Austria
- Sanofi-Aventis Administrative Office Laval, Canada
- Sanofi-Aventis Administrative Office Berlin, Germany
NCT00344253
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +12 more
- Locations
-
- Interdisciplinary Uveitis Center, University of Heidelberg Heidelberg, Germany
NCT01171209
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
Not specified
Completed
Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
NCT00206635
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Many Locations, Alabama, United States
- Many Locations, Arizona, United States
- Many Locations, California, United States
- Many Locations, Illinois, United States
NCT01500408
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Research Site Saint Paul, Minnesota, United States
NCT00618527
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- The Ohio State University Multiple Sclerosis Center Columbus, Ohio, United States
NCT00475865
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +8 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
- Sanofi-Aventis Administrative Office Vienna, Austria
- Sanofi-Aventis Administrative Office Laval, Canada
- Sanofi-Aventis Administrative Office Berlin, Germany